🇺🇸 FDA
Patent

US 9266901

Compositions and methods for treating cancer

granted A61KA61K31/365A61K31/443

Quick answer

US patent 9266901 (Compositions and methods for treating cancer) held by The Regents of the University of California expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/365, A61K31/443, A61K31/4525, A61K45/06